4 responses to “An Update: BPH Management for Family Physicians”

  1. As routine PSA is not covered by MSP and my patients will be unwilling to pay for it,I rely more on my digital exam to determine the use of PSA accordingly.

  2. It is important to understand that the suggested use of PSA in Dr. Ngui’s article is not for prostate cancer screening. These are symptomatic patients and the PSA is part of the evaluation of these patients. Not only does it help rule out prostate cancer, it helps to assess the future risk of progression of BPH, and in this respect helps to guide treatment (especially the use of a 5 alpha reductase inhibitor). The cost of the PSA in a patient with BPH is covered by MSP so that this should not be an issue.

  3. Useful aproach.

  4. useful information all in one place- a good reference for me, with 80% female patients– this helps when a male wanders in.

Leave a Reply